ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,207.05
0.68%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSX
  6. VIVO Cannabis Inc (LABS)

  7. VIVO Cannabis Inc (LABS) Noticias

LABS

VIVO Cannabis (LABS)

VIVO Cannabis Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:LABS
FechaHoraFuenteTítuloSímboloCompañía
08/05/202415:30PR Newswire (US)MediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
27/03/202409:54PR Newswire (Canada)MediPharm Labs Provides Conference Call Recording DetailsTSX:LABSVIVO Cannabis Inc
27/03/202405:30PR Newswire (US)MediPharm Labs Reports Fourth Quarter and Full Year ResultsTSX:LABSVIVO Cannabis Inc
25/03/202405:30PR Newswire (Canada)MediPharm Labs Provides Update on German Cannabis LegalizationTSX:LABSVIVO Cannabis Inc
22/03/202405:30PR Newswire (US)MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
07/02/202405:30PR Newswire (US)MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health AuthorityTSX:LABSVIVO Cannabis Inc
22/12/202306:00PR Newswire (US)MediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramTSX:LABSVIVO Cannabis Inc
14/11/202306:15PR Newswire (US)MediPharm Labs Reports Third Quarter ResultsTSX:LABSVIVO Cannabis Inc
08/11/202316:01PR Newswire (US)MediPharm Labs Sets Date to Report Third Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
25/10/202306:00PR Newswire (US)MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to CashTSX:LABSVIVO Cannabis Inc
02/10/202306:00PR Newswire (US)MediPharm Labs Settles an Outstanding Claim for $9MTSX:LABSVIVO Cannabis Inc
27/09/202306:15PR Newswire (Canada)MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketTSX:LABSVIVO Cannabis Inc
20/09/202306:00PR Newswire (US)MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementTSX:LABSVIVO Cannabis Inc
05/09/202306:39PR Newswire (US)MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 millionTSX:LABSVIVO Cannabis Inc
31/08/202307:02PR Newswire (US)MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia PatientsTSX:LABSVIVO Cannabis Inc
14/08/202306:13PR Newswire (Canada)MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin GrowthTSX:LABSVIVO Cannabis Inc
10/08/202316:00PR Newswire (Canada)MediPharm Labs Sets Date to Report Second Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
01/08/202306:00PR Newswire (US)MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA StatusTSX:LABSVIVO Cannabis Inc
22/06/202316:50PR Newswire (Canada)MediPharm Labs Announces Change of AuditorTSX:LABSVIVO Cannabis Inc
15/05/202306:07PR Newswire (Canada)MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDATSX:LABSVIVO Cannabis Inc
10/05/202316:17PR Newswire (Canada)MediPharm Labs Sets Date to Report First Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
13/04/202306:00PR Newswire (Canada)MediPharm Labs Provides Update on VIVO Integration and Board AppointeeTSX:LABSVIVO Cannabis Inc
03/04/202306:00PR Newswire (Canada)MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership RatioTSX:LABSVIVO Cannabis Inc
31/03/202306:15PR Newswire (Canada)MediPharm Labs Reports Fourth Quarter and Full Year 2022 ResultsTSX:LABSVIVO Cannabis Inc
28/03/202316:00PR Newswire (Canada)MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial ResultsTSX:LABSVIVO Cannabis Inc
21/03/202318:26PR Newswire (Canada)MediPharm Labs Corp. Announces Voting Results From Special Meeting of ShareholdersTSX:LABSVIVO Cannabis Inc
06/03/202312:59PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - LABS.WTTSX:LABSVIVO Cannabis Inc
06/03/202312:48PR Newswire (Canada)IIROC Trading Halt - LABS.WTTSX:LABSVIVO Cannabis Inc
01/03/202306:30PR Newswire (US)MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner StudyTSX:LABSVIVO Cannabis Inc
21/02/202306:00PR Newswire (Canada)MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.TSX:LABSVIVO Cannabis Inc
 Showing the most relevant articles for your search:TSX:LABS

Su Consulta Reciente

COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
FX
EURUSD
Euro vs US Dollar
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USI
USTECH100
US Tech 100
AMEX
XLV
Health Care Select Sector
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
CCOM
US500
US 500
NYSE
CVX
Chevron
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados